Immunic names Erik Lundgren as CEO as it advances Phase 3 MS trials

Stocks Yahoo Finance By Yahoo Finance 27 May 2026 13:06 1 min read

Immunic names Erik Lundgren as CEO as it advances Phase 3 MS trials

Immunic names Erik Lundgren as CEO as it advances Phase 3 MS trials

Immunic names Erik Lundgren as CEO as it advances Phase 3 MS trials

Read the full story on Yahoo Finance → Opens the original article on finance.yahoo.com

Summary aggregated from Yahoo Finance's public RSS feed. The full reporting belongs to Yahoo Finance — please read it on their site.